On the 15th and 16th July 2014, BERENICE project held its General assembly  in Vitoria, Spain, hosted by CIBER-UPV. During two days all the partner were together, with physical presence of at least one representative from each institution, including partners from Latin America

Fruitful advances were obtained to propose novel formulations as alternatives to those which where first considered, in order to overcome the challenges which appeared during the Project development. Novel experimental designs were proposed for in vitro and in vivo testing, to assess first pass effect by liver metabolism and efficacy.

Novel compounds to be candidates for the clinical testing were also adressed